• Home
  • News

Sichenzia Ross Ference LLP Represents Sharps Technology, Inc. in $16 Million Initial Public Offering

Sharps Technology inc.

Press Release – New York, NY – April 19, 2022 – Sichenzia Ross Ference LLP announced today that it represented Sharps Technology, Inc. (Nasdaq: STSS and STSSW), an innovative medical device company offering patented, best-in-class, single use smart safety syringe products, in its initial public offering of 3,750,000 units at a public offering price of $4.25 per unit, each consisting of one share of common stock and two warrants to purchase one share of common stock.  The gross proceeds from the offering were approximately $16 million, before deducting underwriting discounts, commissions and offering expenses.  

The Sichenzia Ross Ference LLP team was led by partners Arthur Marcus and Jeff Cahlon, and associate Michael Blane. 

Sichenzia Ross Ference LLP
Latest posts by Sichenzia Ross Ference LLP (see all)